Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Real-World Outcomes of CDK4/6 Inhibitors Treatment in Metastatic Breast Cancer in Romania
Andreea-Iuliana Miron, Alexandra-Valentina Anghel, Andrei-Alexandru Barnonschi, et al.
Diagnostics (2023) Vol. 13, Iss. 11, pp. 1938-1938
Open Access | Times Cited: 16

Showing 16 citing articles:

Comparative overall survival of CDK4/6 inhibitors plus an aromatase inhibitor in HR+/HER2− metastatic breast cancer in the US real-world setting
Hope S. Rugo, Rachel M. Layman, Filipa Lynce, et al.
ESMO Open (2025) Vol. 10, Iss. 1, pp. 104103-104103
Open Access | Times Cited: 3
Prediction of Subclinical and Clinical Multiple Organ Failure Dysfunction in Breast Cancer Patients—A Review Using AI Tools
Andreea-Iuliana Miron, Dimitrie-Ionuț Atasiei, Radu Tudor Ionescu, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 381-381
Open Access | Times Cited: 10
Assessing the Impact of Organ Failure and Metastases on Quality of Life in Breast Cancer Patients: A Prospective Study Based on Utilizing EORTC QLQ-C30 and EORTC QLQ-BR45 Questionnaires in Romania
Andreea-Iuliana Miron, Alexandra-Valentina Anghel, Ionuț-Lucian Antone-Iordache, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 2, pp. 214-214
Open Access | Times Cited: 9
The Impact on Survival of Neoadjuvant Treatment Interruptions in Locally Advanced Rectal Cancer Patients
Horia-Dan Lișcu, Ionuț-Lucian Antone-Iordache, Dimitrie-Ionuț Atasiei, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 3, pp. 266-266
Open Access | Times Cited: 5
Local Control of Advanced Breast Cancer—Debate in Multidisciplinary Tumor Board
Iuliana Pantelimon, Andra Maria Stancu, Simona Coniac, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 510-510
Open Access
Phyllodes Tumor of the Breast: A Case Report Regarding the Importance of Fast Interdisciplinary Management
Horia-Dan Lișcu, Andreea-Iuliana Miron, Iman Mologani, et al.
Reports — Medical Cases Images and Videos (2025) Vol. 8, Iss. 1, pp. 17-17
Open Access
Initial real-world experience with ribociclib in advanced breast cancer
Azhar Nawaz, Jamal Zekri, Haleem J. Rasool, et al.
Journal of Oncology Pharmacy Practice (2025)
Closed Access
Real-world effectiveness comparison of first-line palbociclib, ribociclib or abemaciclib plus endocrine therapy in advanced HR+/HER2- BC patients: results from the multicenter PALMARES-2 study
L. Provenzano, M.V. Dieci, G. Curigliano, et al.
Annals of Oncology (2025)
Closed Access
Real-World Data Analysis of CDK4/6 Inhibitor Therapy—A Patient-Centric Single Center Study
Isabell Ge, Kai Berner, Marlene Mathis, et al.
Cancers (2024) Vol. 16, Iss. 9, pp. 1760-1760
Open Access | Times Cited: 2
Real-World Data with CDK4/6 Inhibitors—A Single Center Experience from Croatia
Iva Skočilić, Marin Golčić, Ana Marija Bukovica, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 9, pp. 895-895
Open Access | Times Cited: 2
Early Presentation of Boerhaave Syndrome in the Emergency Department: A Case Report and Review of the Literature
Irina-Anca Eremia, C.G. Anghel, Florina-Alexandra Cofaru, et al.
Diagnostics (2024) Vol. 14, Iss. 15, pp. 1592-1592
Open Access | Times Cited: 1
Efficacy and Safety of Cyclin-Dependent Kinase 4/6 Inhibitors in Patients with Breast Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials and Real-World Studies
Hui‐Chen Su, Ho-Wei Lin, Ka‐Wai Tam
Targeted Oncology (2024)
Closed Access | Times Cited: 1
Effectiveness of cyclin-dependent kinase 4 and 6 inhibitors for the treatment of hormonesensitive HER2-negative metastatic breast cancer in first-line therapy: A systematic literature review
N. А. Avxentyev, I. I. Andreyashkina, Е. В. Артамонова, et al.
Tumors of female reproductive system (2024) Vol. 20, Iss. 1, pp. 64-81
Open Access
Pharmacodynamic characteristics, safety profile, and interactions of CDK4/6 inhibitors (CDK4/6i) in HR+/HER2– advanced/metastatic breast cancer
Antria Savvidou, Stavroula Kitiri, Lefteris C. Zacharia, et al.
European Journal of Oncology Pharmacy (2024) Vol. 7, Iss. 2
Closed Access
Gynecological Insights into Lynch Syndrome—A Comprehensive Review of Cancer Screening and Prevention
Elena Chitoran, Roxana Elena Bohîlțea, Vlad Rotaru, et al.
Medicina (2024) Vol. 60, Iss. 12, pp. 2013-2013
Open Access
Palbociclib in real clinical practice: Results of a single-center observational study
А. В. Султанбаев, I. V. Kolyadina, А. Ф. Насретдинов, et al.
Meditsinskiy sovet = Medical Council (2024), Iss. 21, pp. 42-50
Open Access
Page 1

Scroll to top